Skip to content
Home/Companies/Biotech/Transcripta Bio
TB

Transcripta Bio

Biotech·United States·Active·6yr hold

Transcripta Bio is a biotech company, headquartered in United States.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns Transcripta Bio?

Transcripta Bio is currently owned by BlueYard Capital through BlueYard Capital Fund II (2019 vintage), since 2020.

Hand-verified · updated 2026-07-17

BlueYard Capital
Investor
BlueYard Capital
BlueYard Capital Fund II · 2019 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from BlueYard Capital Fund II

Other portfolio companies in the same fund.

Dance
Exited 2026
MobilityGermany· 2020
to
Insempra
Active
BiotechGermany· 2020
SEEQC
Active
Deep TechUnited States· 2020
bit.bio
Active
BiotechUnited Kingdom· 2019
Grid
Active
SoftwareIceland· 2019
Marvel Fusion
Active
EnergyGermany· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Adcendo
Active
Jeito CapitalDenmark· 2026
Data refreshed weekly · Sourced from public filings